Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Significant increase of benign endometrial cells on Papanicolaou smears in women using hormone replacement therapy.

Mount SL, Wegner EK, Eltabbakh GH, Olmstead JI, Drejet AE.

Obstet Gynecol. 2002 Sep;100(3):445-50.

PMID:
12220762
2.
3.

Postmenopausal hormone replacement therapy: endometrial and breast effects.

Yeh IT.

Adv Anat Pathol. 2007 Jan;14(1):17-24. Review.

PMID:
17198307
4.

The significance of benign endometrial cells in cervicovaginal smears.

Fadare O, Ghofrani M, Chacho MS, Parkash V.

Adv Anat Pathol. 2005 Sep;12(5):274-87. Review.

PMID:
16210924
5.

The risks and benefits of hormonal replacement therapy in healthy women and in breast cancer survivors.

Welnicka-Jaskiewicz M, Jassem J.

Cancer Treat Rev. 2003 Oct;29(5):355-61. Review.

PMID:
12972354
6.

Hormone replacement therapy (HRT) and endometrial morphology under consideration of the different molecular pathways in endometrial carcinogenesis.

Horn LC, Dietel M, Einenkel J.

Eur J Obstet Gynecol Reprod Biol. 2005 Sep 1;122(1):4-12. Review.

PMID:
15927347
7.

Disturbances of endometrial bleeding with hormone replacement therapy.

Thomas AM, Hickey M, Fraser IS.

Hum Reprod. 2000 Aug;15 Suppl 3:7-17. Review.

PMID:
11041216
8.

Endometrial safety of hormone replacement therapy: review of literature.

Van Gorp T, Neven P.

Maturitas. 2002 Jun 25;42(2):93-104. Review.

PMID:
12065168
9.

Prevalence of psammoma bodies in Papanicolaou-stained cervicovaginal smears.

Kern SB.

Acta Cytol. 1991 Jan-Feb;35(1):81-8. Review.

PMID:
1994642
10.

HRT, breast and endometrial cancers: strategies and intervention options.

Sismondi P, Biglia N, Giai M, Ponzone R, Roagna R, Sgro L, Campagnoli C.

Maturitas. 1999 Aug 16;32(3):131-9. Review.

PMID:
10515669
11.

[Is it possible to screen for endometrial carcinoma? Incidence and risk factors].

Broso PR, Giradi F.

Minerva Ginecol. 1995 Dec;47(12):539-52. Review. Italian.

PMID:
8720976
12.

Hormone replacement therapy and the endometrium.

Feeley KM, Wells M.

J Clin Pathol. 2001 Jun;54(6):435-40. Review.

13.

[Endometrial brush biopsy in monitoring endometrial cytology during hormone replacement therapy].

Belowska A.

Ginekol Pol. 2004 Jun;75(6):475-81. Review. Polish.

PMID:
15524425
14.

Psammoma bodies in cervicovaginal smears: incidence and significance.

Parkash V, Chacho MS.

Diagn Cytopathol. 2002 Feb;26(2):81-6. Review.

PMID:
11813323
15.

Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women.

Salpeter SR, Cheng J, Thabane L, Buckley NS, Salpeter EE.

Am J Med. 2009 Nov;122(11):1016-1022.e1. doi: 10.1016/j.amjmed.2009.05.021. Review.

PMID:
19854329
16.

[Hormonal replacement therapy and inflammatory response--update].

Zeltser D, Berliner S, Shapira I.

Harefuah. 2001 Nov;140(11):1046-8, 1116. Review. Hebrew.

PMID:
11759379
17.

Life-style and metformin for the prevention of endometrial pathology in postmenopausal women.

Campagnoli C, AbbĂ  C, Ambroggio S, Brucato T, Pasanisi P.

Gynecol Endocrinol. 2013 Feb;29(2):119-24. doi: 10.3109/09513590.2012.706671. Epub 2012 Sep 5. Review.

PMID:
22946682
18.

Problems of endometrial histology interpretation.

Bergeron C.

Climacteric. 2000 Dec;3(4):288-93. Review. No abstract available.

PMID:
11910589
19.

The wisdom of hormone-replacement therapy in survivors of ovarian and endometrial cancer.

Lin K, Runowicz CD.

Surg Clin North Am. 2001 Aug;81(4):987-93. Review.

PMID:
11551137
20.

Hormone replacement therapy after treatment for a gynaecological malignancy.

O'Donnell RL, Clement KM, Edmondson RJ.

Curr Opin Obstet Gynecol. 2016 Feb;28(1):32-41. doi: 10.1097/GCO.0000000000000238. Review.

PMID:
26626038

Supplemental Content

Support Center